Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.

Dominic BettingerRenan SpodeNicolas GlaserNico BuettnerTobias BoettlerChristoph Neumann-HaefelinThomas Baptist BrunnerEleni GkikaLars MaruschkeRobert ThimmeMichael Schultheiss

Published in: BMC gastroenterology (2017)

In metastatic HCC, treatment of intrahepatic tumor by TACE may be associated with improved survival. These results support the prognostic importance of treating intrahepatic HCC even in patients with metastatic disease. Therefore, we suggest evaluating the technical feasibility of TACE in all metastatic patients.

Keyphrases

end stage renal disease
squamous cell carcinoma
small cell lung cancer
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
radiofrequency ablation
free survival
combination therapy